Tenecteplase Bridging Thrombolysis Prior to Inter-hospital Transfer for Endovascular Therapy in Anterior Circulation Large Vessel Occlusion Stroke Within 4.5-24 Hours
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1266 participants.
Also called NCT07912970
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 1,266 participants
- Registry
-
NCT07912970
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07912970. Randomized; single masking; primary purpose treatment. Start 2027-04-01 (anticipated); primary completion 2029-12-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Tenecteplase Bridging Thrombolysis Prior to Inter-hospital Transfer for Endovascular Therapy in Anterior Circulation Large Vessel Occlusion Stroke Within 4.5-24 Hours
- Acronym
- Union-transfer
- Condition
- Acute Ischemic Stroke
- Condition
- Large Vessel Occlusion
- Intervention (Drug)
- Tenecteplase (rhTNK-tPA) (0.25 mg/kg, to maximum of 25mg)
- Lead sponsor
- Fujian Medical University Union Hospital
- Collaborator
- Zhangzhou Affiliated Hospital of Fujian Medical University
Record details
- Record id
cardio:ct-nct07912970- Content hash
76db7395a73bdc2874cb43b2695687141dbdb5ff0f555eac981f2715eb49f8b3